The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Open accessAbstract
BACKGROUND: Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inflammatory markers and involved mainly white persons. It is unclear whether the benefits of statins can be extended to an intermediate-risk, ethnically diverse population without cardiovascular disease. METHODS: In one comparison from a 2-by-2 factorial trial, we randomly assigned 12,705 participants in 21 countries who did not have cardiovascular disease and were at intermediate risk to receive rosuvastatin at a dose of 10 mg per day or placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, and the second coprimary outcome additionally included revascularization, heart failure, and resuscitated cardiac arrest. The median follow-up was 5.6 years. RESULTS: The overall mean low-density lipoprotein cholesterol level was 26.5% lower in the rosuvastatin group than in the placebo group. The first coprimary outcome occurred in 235 participants (3.7%) in the rosuvastatin group and in 304 participants (4.8%) in the placebo group (hazard ratio, 0.76; 95% confidence interval [CI], 0.64 to 0.91; P=0.002). The results for the second coprimary outcome were consistent with the results for the first (occurring in 277 participants [4.4%] in the rosuvastatin group and in 363 participants [5.7%] in the placebo group; hazard ratio, 0.75; 95% CI, 0.64 to 0.88; P<0.001). The results were also consistent in subgroups defined according to cardiovascular risk at baseline, lipid level, C-reactive protein level, blood pressure, and race or ethnic group. In the rosuvastatin group, there was no excess of diabetes or cancers, but there was an excess of cataract surgery (in 3.8% of the participants, vs. 3.1% in the placebo group; P=0.02) and muscle symptoms (in 5.8% of the participants, vs. 4.7% in the placebo group; P=0.005). CONCLUSIONS: Treatment with rosuvastatin at a dose of 10 mg per day resulted in a significantly lower risk of cardiovascular events than placebo in an intermediate-risk, ethnically diverse population without cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; HOPE-3 ClinicalTrials.gov number, NCT00468923.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, there are three large, randomized trials of statin versus placebo where specific cognitive tests were performed, and no differences were seen between statin and placebo (166-169).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, there are three large, randomized trials of statin versus placebo where specific cognitive tests were performed, and no differences were seen between statin and placebo (160–163).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [163]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Heart Outcomes Prevention Evaluation 3 (HOPE-3), published in 2016, showed that low-dose statin therapy reduced the composite cardiovascular outcome by 24% but had no significant effect on mortality.19”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“The effectiveness of statins for preventing the first occurrence and recurrence of stroke in Japanese populations was confirmed in a sub-analysis of the MEGA study620, 621) and in the JELIS study622).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [621]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Self-citationForouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448
Self-citationCollaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Semiparametric regression for the mean and rate functions of recurrent events
Lin, D. Y., Wei, L. J., Yang, I., & Ying, Z. (2000) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00259 · Cited by 969
Flagged first, then by citations
Research works printed but not linked: 1
- Sackett DL, 2000, CMAJ, 162, 1311
Cited by
Sorted by citations
Items 501–600 of 847
Luo, F., Lin, Y., Zhang, X., Li, Y., Su, L., Zhou, S., Xu, R., Gao, Q., Chen, R., Guo, Z., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad354 · Cited by 8
Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events
Al-Ani, A., Jamil, Y., & Orkaby, A. R. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01139-4 · Cited by 6
Klug-entscheiden-Empfehlungen in der Kardiologie
Werdan, K., Baldus, S. E., Frey, N., Nixdorff, U., Kück, K., & Katus, H. A. (2017) · Der Internist · doi:10.1007/s00108-017-0239-7 · Cited by 6
Philosophy of too much medicine conference report
Uusitalo, S., & Howick, J. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13000 · Cited by 6
Hypertension guidelines: Treat patients, not numbers
Aleyadeh, W., Hutt, E., Ahmed, H. M., & Shah, N. P. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.18027 · Cited by 6
Borne, E., Meyer, N., Rybarczyk-Vigouret, M.-C., Blanchard, O., Lombard, M., Lang, P. O., Vogel, T., & Michel, B. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00695-4 · Cited by 6
Asarcıklı, L. D., Kış, M., Güvenç, T. S., Tosun, V., Açar, B., Demir, F. A., Naser, A., Zoghi, M., & CVSCORE‐TR investigators (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14090 · Cited by 6
Gronewold, J., Kropp, R., Lehmann, N., Stang, A., Mahabadi, A. A., Weimar, C., Dichgans, M., Moebus, S., Kröger, K., Hoffmann, B. H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-039597 · Cited by 6
Schade, D. S., Obenshain, S. S., Hickey, M., Febbo, J., Wann, S., & Eaton, R. P. (2022) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2022.126032 · Cited by 6
Zheng, Q., Han, Y., Fan, M., Gao, X., Ma, M., Xu, J., Liu, S., & Ge, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11904 · Cited by 6
Therapie der Hypercholesterinämie in der Primärprävention
Sanin, V., & Köenig, W. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0657-1668 · Cited by 6
Takeuchi, S., Takahashi, Y., & Asai, S. (2020) · Medicine · doi:10.1097/md.0000000000023427 · Cited by 6
Ashfaq, T., Shahzad, F., Ishaq, A., Naseem, S., & Saleem, F. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.93995 · Cited by 6
Stone, N. J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004197 · Cited by 6
Inflammation, venous thromboembolism, and what we can do about it
Glynn, R. J., & Ridker, P. M. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx251 · Cited by 6
Zeron, R. M. C., & de Albuquerque, V. C. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.12.1421 · Cited by 6
Metabolic syndrome, LDL-hypercholesterolaemia, and cerebrocardiovascular risk: sex matters.
Tsaban, G. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa132 · Cited by 6
COVID-19 vaccines: effectiveness and number needed to treat
Correia, L. C. L., & Matias, D. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00119-1 · Cited by 7
Odden, M. C., Zhang, A., Jawadekar, N., Tan, A. X., Moran, A. E., Glymour, M. M., Brayne, C., Hazzouri, A. Z. A., & Calónico, S. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00982-w · Cited by 5
Ki, Y., Kim, W., Lee, K. H., Han, S. J., Kim, Y., Doh, J., Kim, T. N., Chung, C. H., Kim, D. Y., Cho, J., et al. (2025) · Clinical Cardiology · doi:10.1002/clc.70138 · Cited by 5
Jabbar, A. B. A., Naeem, U., Zulfiqar, K., Ahmed, S., Hinkamp, C. A., Inam, M., Minhas, A. M. K., Slipczuk, L. N., Krittanawong, C., Sahebkar, A., et al. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01355-2 · Cited by 5
Lee, J., Kang, M. W., Oh, J., Kim, M., Koh, J. H., Kang, E., Cho, J. M., Cho, S., Kim, S. G., Lee, S., et al. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf105 · Cited by 5
Consensus statement on the management of dyslipidaemias in adults
Béliard, S., Bonnet, F., Bouhanick, B., Bruckert, É., Cariou, B., Charrière, S., Durlach, V., Moulin, P., Valéro, R., & Vergès, B. L. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.11.001 · Cited by 5
Niveles óptimos de colesterol en los pacientes con dislipemia. Revisión sistemática de la evidencia
Escobar, C., Barrios, V., & de Isla, L. P. (2017) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2017.08.006 · Cited by 5
Kim, S. Y., Choi, H., & Won, C. W. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104644 · Cited by 5
Huh, J. H., Park, S. W., Go, T., Kang, D. R., Lee, S., & Kim, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.812416 · Cited by 5
Gallo, G., Sarzani, R., Cicero, A. F. G., Genovese, S., Pirro, M., Gallelli, L., Faggiano, A., & Volpe, M. (2023) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00570-9 · Cited by 6
Diamond, D. M., & Leaverton, P. E. (2023) · Cureus · doi:10.7759/cureus.38391 · Cited by 7
What have clinical trials taught us about brain health?
Lee, K., & Bae, H. (2023) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2023.100199 · Cited by 5
Lipid clinical trials with special reference to Indian population
Aseem Basha, M., & Ramakrishnan, S. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.02.003 · Cited by 5
Bellosillo, B., Doubek, M., Tomuleasa, C., Grießhammer, M., Marchetti, M., Sacha, T., & Gisslinger, H. (2024) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-024-01009-0 · Cited by 7
Guijarro, C., & Camafort, M. (2019) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.05.005 · Cited by 5
La realidad del riesgo cardiovascular en Iberoamérica
López-Jaramillo, P. A., López-López, J., & Yusuf, S. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.02.020 · Cited by 5
Self-citationChen, H., Chang, H.-M., Wu, H., Lin, Y., Chang, Y., Chang, Y.-C., Lee, W.-H., & Chang, C. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104970 · Cited by 5
Statins in Healthy Adults: A Meta-Analysis
Sandwith, L., & Forget, P. (2021) · Medicina · doi:10.3390/medicina57060585 · Cited by 5
Effect of alirocumab on cataracts in patients with acute coronary syndromes
Suc, G., Schwartz, G. G., Goodman, S. G., Jukema, J. W., Manvelian, G. Z., Poulouin, Y., Pordy, R. C., Scemama, M., Szarek, M. J., Steg, P. G., et al. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-03012-1 · Cited by 5
Hyun, M. H., Jang, J. W., Choi, B. G., Na, J. O., Choi, C. U., Kim, J. W., Kim, E. J., Rha, S., Park, C. G., Lee, E. M., et al. (2019) · Medicine · doi:10.1097/md.0000000000018510 · Cited by 5
Mancini, G. B. J., & Hegele, R. A. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.02.027 · Cited by 5
Evolving Approaches for Statins in Primary Prevention
Návar, A. M., & Peterson, E. D. (2016) · JAMA · doi:10.1001/jama.2016.15094 · Cited by 5
Statin Therapy on the Basis of HOPE
Falk, E., & Mortensen, M. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.002 · Cited by 5
Lin, S., Lin, L., Peng, W., Liu, X., Li, X., Lu, J., & Wu, S. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101007 · Cited by 4
WHF Roadmap on Single Pill Combination Therapies
Ferro, E. G., Satheesh, G., Castellano, J. M., Damasceno, A. A. M., Erojikwe, O., Huffman, M. D., Irazola, V. E., Joseph, P. G., Lanas, F. T., Ogola, E. N., et al. (2025) · Global Heart · doi:10.5334/gh.1457 · Cited by 4
Rossi, R., Nouri, A., Akman, Z., Nezhad, S. A., Damluji, A. A., & Nanna, M. G. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02329-1 · Cited by 5
Edwards, A., Singh, P., Shah, V., Chander, V., & Mishra, S. (2026) · Cells · doi:10.3390/cells15060529 · Cited by 4
Statin therapy in individuals with intermediate cardiovascular risk
Kim, J., Kim, H., Park, S. H., Kang, Y., Han, K., & Lee, S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155723 · Cited by 4
Agreement Between Mega-Trials and Smaller Trials
Kastrati, L., Raeisi‐Dehkordi, H., Llanaj, E., Quezada‐Pinedo, H. G., Khatami, F., Ahanchi, N. S., Llane, A., Meçani, R., Muka, T., & Ioannidis, J. P. A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.32296 · Cited by 5
Palermi, S., Vecchiato, M., Brusiani, S., Martino, L. D., Luca, M. D., Fernando, F., Cavarretta, E., Niebauer, J., Volpe, M., & Biffi, A. (2025) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-025-00722-z · Cited by 4
Statin use for primary prevention of cardiovascular disease among apparently healthy adults
Halili, A., Eroglu, T. E., Torp-Pedersen, C. T., & Zareini, B. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf357 · Cited by 4
Facing cardiovascular risk in Ibero-America
López-Jaramillo, P. A., López-López, J., & Yusuf, S. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.02.014 · Cited by 4
Self-citationStatin Therapy in HIGH-Risk Individuals with NORMal Coronary Arteries: The HIGH-NORM Study
Chun, K., Park, J. M., Lee, C. J., Oh, J., Park, S., Kang, S., & Lee, S.-H. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63004 · Cited by 4
Borden, W. B., Wang, J., Jones, P. G., Tang, Y., Contreras, J., Daugherty, S. L., Desai, N. R., Virani, S. S., Wasfy, J. H., & Maddox, T. M. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.121.007908 · Cited by 4
Golbon, B., Habashi, R., Shellenberger, J. P., Griffiths, R., Avery, L., Woo, M., Pincus, D., Eskander, A. E., & Pasternak, J. D. (2024) · Surgery · doi:10.1016/j.surg.2024.08.052 · Cited by 4
Bejjani, A., Khairani, C. D., Krishnathasan, D., Rizzo, S. M., Sato, A., Bacare, B., Scimeca, G., Tristani, A., Armero, A., Porio, N. D., et al. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf109 · Cited by 5
Suwaidi, J. M. S. A. (2016) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2016.13 · Cited by 4
Combined use of short-term and long-term cardiovascular risk scores in primary prevention
Veronesi, G., Giampaoli, S., Vanuzzo, D., Gianfagna, F., Palmieri, L., Grassi, G. M., Cesana, G., & Ferrario, M. (2017) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000509 · Cited by 4
Nedogoda, S. V., Chumachek, E. V., Ledyaeva, A. A., Цома, В. В., Salasyuk, A. S., Смирнова, В. О., Khripaeva, V. Y., Витальевич, П. Р., & Popova, E. A. (2018) · Systemic Hypertension · doi:10.26442/2075-082x_2018.2.24-31 · Cited by 4
Cardiovascular Risk Factor Modification in Asymptomatic Adults and Implications for Pilots
Wirawan, I. M. A., Griffiths, R. F., & Larsen, P. (2020) · Journal of UOEH · doi:10.7888/juoeh.42.187 · Cited by 4
Impact of statin intake on malignant hyperthermia: an in vitro and in vivo swine study
Gonzalez, A. A., Iles, T. L., Iaizzo, P. A., & Bandschapp, O. (2020) · BMC Anesthesiology · doi:10.1186/s12871-020-01186-5 · Cited by 4
Statin therapy for primary cardiovascular prevention in adults older than 75 years
Rasmussen, P. A., Yandrapalli, S., & Aronow, W. S. (2021) · Kardiologia Polska · doi:10.33963/kp.15743 · Cited by 4
Lee, M., Mahtta, D., Alam, M., Ullah, W., Nasir, K., Hanif, B., & Virani, S. S. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1888718 · Cited by 4
Should a Statin be Given to All Hypertensive Patients?
McNavish, D., German, C. A., & Shapiro, M. D. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01167-8 · Cited by 4
Lin, Y., Lip, G. Y. H., Ho, W., Shi, C., Lin, M., Kuo, T., Chung, C., Chang, S., Chen, Y., Chen, H., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.01.029 · Cited by 4
Potential of combination therapy in patients with hypertension and dyslipidemia
Владимировна, Г. Т., & Перепеч, Н. Б. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5132 · Cited by 4
LDL-C Targets in Secondary Prevention: How Low Should We Go?
Bayoumy, K., Gaber, M., Mani, P., Puri, R., Donnellan, E., Cho, L., Clark, D., Martin, S. S., & Elshazly, M. B. (2019) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-019-0619-8 · Cited by 4
The Rationale for a Different Approach to Preventing Cardiovascular Disease
Schade, D. S., Ramo, B. W., Obenshain, S. S., Schrader, R., & Eaton, R. P. (2019) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2019.97043 · Cited by 4
The Debate Over Egg Consumption and Incident Cardiovascular Disease
Chrysant, S. G., & Chrysant, G. S. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000325 · Cited by 4
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
Bubnova, M. G., Il'chenko, M. Y., & Lebedev, P. A. (2021) · Cardiosomatics · doi:10.26442//22217185.2021.2.200859 · Cited by 4
Pedro‐Botet, J., Barrios, V., Sánchez‐Margalet, V., Tamargo, J. L., Arrieta, F., Gámez, J. M., Gimeno-Orna, J. A., Escobar, C., Gómez‐Doblas, J. J., & Pérez, A. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.03.004 · Cited by 5
Campbell, D. J. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0396-y · Cited by 4
Lessons learned from Systolic Blood Pressure Intervention Trial
Whelton, P. K., Chen, J., & Krousel-Wood, M. A. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000396 · Cited by 4
Management verschiedener kardiovaskulärer Risikofaktoren mit einem Kombinationspräparat („Polypill“)
Bramlage, P., März, W., Westermann, D., Weisser, B., Wirtz, J., Zeymer, U., Baumgart, P., van Mark, G., Laufs, U., Krämer, B. K., et al. (2017) · Herz · doi:10.1007/s00059-017-4554-5 · Cited by 4
Muniyappa, R., Noureldin, R., Abd‐Elmoniem, K. Z., Khouli, R. H. E., Matta, J. R., Hamimi, A., Ranganath, S., Hadigan, C. M., Nieman, L. K., & Gharib, A. M. (2018) · Cardiorenal Medicine · doi:10.1159/000487205 · Cited by 4
Saint-Gerons, D. M., & Castro, J. L. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2587-1 · Cited by 4
Stone, N. J., & Lloyd‐Jones, D. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.027 · Cited by 4
Low-Density Lipoprotein Cholesterol and the On-Target Effects of Therapy
Everett, B. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.036 · Cited by 4
Ray, K. K., & Kastelein, J. J. P. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw428 · Cited by 4
Yamashita, S., Araki, E., Arai, H., Yokote, K., Tanigawa, R., Kunitomi, K., Ikegami, K., Suganami, H., Tanahashi, M., Minamikawa, S., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.01.008 · Cited by 3
Review of Lipid-Lowering Therapy in Women from Reproductive to Postmenopausal Years
Witting, C. S., Devareddy, A., & Rodríguez, F. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2305183 · Cited by 5
Zheng, X., Zhu, Y., Tang, L., Zhou, Q., Xu, L., Xu, D., Zhao, Y., Lv, J., & Yang, L. (2024) · Nephrology · doi:10.1111/nep.14411 · Cited by 3
Detecting irregularities in randomized controlled trials using machine learning
Nelson, W., Petch, J., Ranisau, J., Zhao, R., Balasubramanian, K., & Bangdiwala, S. I. (2024) · Clinical Trials · doi:10.1177/17407745241297947 · Cited by 3
Sepanlou, S. G., Mousavi, S., Poustchi, H., Malekzadeh, F., Roshandel, G., & Malekzadeh, R. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200400 · Cited by 3
Prabhakar, A. P., Vedamurthy, D., & Kalra, D. K. (2025) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-025-00764-x · Cited by 3
Yebyo, H. G., Günthard, H. F., Rehfuess, E. A., Serra, N., Haile, S. R., Senn, O., Lucas, G. M., Langselius, O., Thorne, J. E., Marconi, V. C., et al. (2025) · BMJ Medicine · doi:10.1136/bmjmed-2024-001132 · Cited by 3
Scherbaum, W. A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0234-6 · Cited by 3
Burstein, B. J., Altobelli, K. K., Williams, K., Cannon, C. P., Pencina, M. J., Sniderman, A. D., & Thanassoulis, G. (2017) · Circulation · doi:10.1161/circulationaha.117.029102 · Cited by 3
Faut-il arrêter les statines chez les personnes âgées ?
Bonnet, F. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2017.10.426 · Cited by 3
Dagenais, G. R., Jung, H. J., Lonn, E., Bogaty, P. M., Dehghan, M., Held, C., Avezum, Á., Janský, P., Keltai, M., Leiter, L. A., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008918 · Cited by 3
Self-citationÚjabb lipidológiai evidenciák és ajánlások
Bajnok, L. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31192 · Cited by 3
Masson, W. M., Lobo, M., Huerin, M. S., Molinero, G., Lobo, L., & Nogueira, J. P. (2018) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2018.11.003 · Cited by 4
Rodríguez, Á. D., & Morató, T. M. (2019) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2019.10.004 · Cited by 3
Tunoa, J., Billups, S. J., Lowe, R. N., & Saseen, J. J. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.09.001 · Cited by 3
Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
Kobalava, Z. D., & Кохан, Е. В. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-09-01 · Cited by 3
Astigmatism among children in Jeddah, Saudi Arabia: prevalence and associated factors
Basheikh, A. A., Howldar, S., Basendwah, M., Baqais, R. T., Bamakrid, M., & Alhibshi, N. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.93976 · Cited by 3
Use of eye drops self-medication in Aseer region, Southern Saudi Arabia
Alamri, A. M., Asiri, R., Al-Nami, A., Hijazi, R., & Almobty, L. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.93984 · Cited by 2
The Role of Statins in Prevention of Cardiovascular Diseases in Real Clinical Practice
IuA, K., & Moscow, R. F. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-11-17-27 · Cited by 4
Lipid-Targeted Atherosclerotic Risk Reduction in Older Adults: A Review
Hassen, L. J., Scarfone, S. R., & Milks, M. W. (2022) · Geriatrics · doi:10.3390/geriatrics7020038 · Cited by 3
Chaure-Pardos, A., Aguilar‐Palacio, I., Rabanaque, M. J., Lallana, M. J., Maldonado, L., Castel-Feced, S., Librero, J., Casasnovas, J. A., & Malo, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050658 · Cited by 3
Sud, M. K., Chu, A., Austin, P. C., Naimark, D. M. J., Thanassoulis, G., Wijeysundera, H. C., & Ko, D. T. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcac044 · Cited by 3
Jain, R., Stone, J. A., Agarwal, G., Andrade, J. G., Bacon, S., BAJAJ, H. S., Baker, B., Cheng, G., Dannenbaum, D. A., Gelfer, M., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220138-f · Cited by 4
Mendivil, C. O., Amaya-Montoya, M., Vargas, J. A. H., Ramírez-García, N., Herrera-Parra, L. J., Guatibonza-García, V., Romero-Díaz, C., Pérez-Londoño, A., & Acuña-Merchán, L. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1073833 · Cited by 6
Metadata
- Authors
- Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., Pais, P., López-Jaramillo, P., Leiter, L. A., Dans, A., Avezum, A., Piegas, L. S., Parkhomenko, A., Keltai, K., Keltai, M., Sliwa, K., Peters, R. J. G., Held, C., Chazova, I., Yusoff, K., Lewis, B. S., Jansky, P., Khunti, K., Toff, W. D., Reid, C. M., Varigos, J., Sanchez-Vallejo, G., McKelvie, R., Pogue, J., Jung, H., Gao, P., Diaz, R., & Lonn, E.
- Affiliations
- St. Michael's Hospital (CA)
- Semmelweis University (HU)
- Uppsala University (SE)
- ORCID
- Yusuf, Salim
- Bosch, Jackie
- Dagenais, Gilles
- Zhu, Jun
- Xavier, Denis
- Liu, Lisheng
- Pais, Prem
- López-Jaramillo, Patricio
- Leiter, Lawrence A.
- Piegas, Leopoldo S.
- Parkhomenko, Alexander
- Keltai, Katalin
- Sliwa, Karen
- Peters, Ron J.G.
- Held, Claes
- Chazova, Irina
- Yusoff, Khalid
- Lewis, Basil S.
- Khunti, Kamlesh
- Toff, William D.
- Reid, Christopher M.
- McKelvie, Robert
- Jung, Hyejung
- Lonn, Eva
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-05-26
- Volume
- 374
- Issue
- 21
- Pages
- 2021-2031
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2313998826
- Cited by
- 848
- References
- 23
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 61 · 2023: 66 · 2022: 84 · 2021: 90 · 2020: 75 · 2019: 109 · 2018: 101 · 2017: 97 · 2016: 78
- FWCI
- 142.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- AstraZeneca
- Canadian Institutes of Health Research (IR2-91038))
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- rosuvastatin, statins, cholesterol lowering, intermediate cardiovascular risk, primary prevention, cardiovascular events, LDL cholesterol, ethnic diversity, C-reactive protein, cataract surgery, statin adverse effects, muscle symptoms, diabetes risk, cardiovascular mortality, myocardial infarction, stroke, heart failure, revascularization, cardiac arrest, cardiovascular risk stratification, lipid-lowering therapy
- MeSH terms
- Rosuvastatin Calcium, Aged, Cardiovascular Diseases, Double-Blind Method, Female, Humans, Hypercholesterolemia, Cholesterol, LDL, Male, Middle Aged, Risk Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
